HEMLIBRA®

FDA INDICATION: Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients who have hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors Package Insert

CLASS: Monoclonal antibody

DISTRIBUTOR: Genentech

VIAL SIZE: 30, 60, 105, 150 mgs

MIXING DEVICE: Double-ended transfer needle

STORAGE: Store vials in a refrigerator at 2–8°C (36–46°F) in the original carton to protect from light. Do not freeze. Do not shake. Prior to administration, if needed, unopened vials may be stored out of and then returned to refrigeration. The temperature and total combined time out of refrigeration should not exceed 30°C (86°F) and 7 days (at a temperature below 30°C [86°F]), respectively.

HALF-LIFE: 27.8 ± 8.1 days

OTHER WEBSITES: gene.com/topics/hemophilia, genentechhemophilia.com, hemlibra.com